2m 2m 2m 2m 2m 2m 2m
Champns Onclgy (CSBR)
NASDAQ
$4.96-$0.00010 (-0.002%)
Price as of Aug 21, 2026 7:30 PM EDT- $68.9MMarket Cap
- -34.99%1-Year Change
- BiotechnologyIndustry
Champns Onclgy (CSBR)
$4.96-$0.00010 (-0.002%)
Annual
Quarterly
04/30/2026 | 04/30/2025 | 04/30/2024 | 04/30/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 59.4M +4.36% | 56.9M +13.54% | 50.2M -6.90% | 53.9M +9.69% | |
Cost of Revenue | 30.9M +8.84% | 28.4M -3.44% | 29.4M -0.44% | 29.5M +24.97% | |
Gross Profit | 28.5M -0.11% | 28.6M +37.59% | 20.8M -14.73% | 24.3M -4.47% | |
Sales and Marketing Expense | 9.3M +23.50% | 7.5M +6.81% | 7.1M +0.89% | 7.0M +9.77% | |
Research and Development Expense | -9.1M +33.10% | -6.8M -28.49% | -9.5M -17.33% | -11.5M +23.16% | |
Depreciation and Amortization Expense | 1.4M -16.04% | 1.6M -12.16% | 1.9M -16.87% | 2.2M +38.05% | |
Total Operating Expenses | 30.9M +8.84% | 28.4M -3.44% | 29.4M -0.44% | 29.5M +24.97% | |
Operating Profit | -1.1M -125.04% | 4.6M +161.90% | -7.4M +39.95% | -5.3M -965.90% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 211,000 +189.04% | 73,000 +52.08% | 48,000 +536.36% | -11,000 -54.17% | |
Income before Taxes | -929,000 -120.08% | 4.6M +163.30% | -7.3M +38.75% | -5.3M -1,003.43% | |
Income Taxes | 246,000 +428.00% | -75,000 +134.38% | -32,000 -147.06% | 68,000 +94.29% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -1.2M -124.99% | 4.7M +164.61% | -7.3M +36.38% | -5.3M -1,073.54% | |
Net Income from Continuing Operations Applicable to Common | -929,000 -120.08% | 4.6M +163.30% | -7.3M +38.75% | -5.3M -1,003.43% | |
Basic EPS and Net Income | -0.08 -123.53% | 0.34 +162.96% | -0.54 +38.46% | -0.39 -1,075.00% | |
Diluted EPS and Net Income | -0.08 -124.24% | 0.33 +161.11% | -0.54 +38.46% | -0.39 -1,075.00% | |
Basic Weighted Average Shares | 13.8M +1.26% | 13.7M +0.83% | 13.5M +0.04% | 13.5M +2.61% | |
Diluted Weighted Average Shares | 13.8M -3.04% | 14.3M +5.31% | 13.5M +0.04% | 13.5M -4.37% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 4.9M -50.21% | 9.8M +273.76% | 2.6M -74.13% | 10.1M +12.33% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 4.9M -50.21% | 9.8M +273.76% | 2.6M -74.13% | 10.1M +12.33% | |
Total Current Assets | 19.2M -14.08% | 22.4M +64.01% | 13.6M -29.90% | 19.5M -1.05% | |
Accumulated Depreciation | 12.9M +10.30% | 11.7M +12.48% | 10.4M +20.41% | 8.6M +54.74% | |
Property and Plant and Equipment and Net | 3.5M -19.41% | 4.4M -23.53% | 5.7M -20.39% | 7.2M +0.73% | |
Total Long-Term Assets | 212,000 +14.59% | 185,000 0.00% | 185,000 +1,133.33% | 15,000 0.00% | |
Total Assets | 27.0M -16.56% | 32.3M +23.77% | 26.1M -23.84% | 34.3M -3.02% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 19.9M -16.48% | 23.9M +10.73% | 21.5M -0.88% | 21.7M +24.34% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 7,000 -91.76% | 85,000 -78.80% | 401,000 -27.22% | 551,000 +40.92% | |
Total Liabilities | 22.9M -19.78% | 28.6M +1.92% | 28.0M -5.53% | 29.7M +12.91% | |
Retained Earnings | -81.1M +1.47% | -79.9M -5.56% | -84.6M +9.41% | -77.3M +7.41% | |
Total Stockholders Equity | 3.9M +4.43% | 3.8M +298.21% | -1.9M -141.05% | 4.6M -49.03% | |
Total Shares Outstanding | 13.9M +0.80% | 13.8M +1.61% | 13.6M +0.11% | 13.5M +0.16% | |
Cash Flow | |||||
Cash from Operating Activities | -4.5M -160.55% | 7.4M +220.35% | -6.1M -254.51% | 4.0M -38.86% | |
Capital Expenditures | 564,000 +44.99% | 389,000 -53.47% | 836,000 -70.89% | 2.9M +20.47% | |
Cash from Investing Activities | -540,000 +38.82% | -389,000 -53.47% | -836,000 -70.89% | -2.9M +20.47% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 99,000 -41.76% | 170,000 +132.26% | -527,000 -4,890.91% | 11,000 -94.69% | |
Financials Ratio | |||||
Gross Margin | 48.00% -4.28% | 50.15% +21.18% | 41.38% -8.41% | 45.18% -12.91% | |
Operating Margin | -1.92% -123.99% | 8.00% +154.52% | -14.67% +50.32% | -9.76% -889.39% | |
Return on Assets | -3.96% -124.63% | 16.08% +166.78% | -24.08% +57.24% | -15.31% -979.68% | |
Return on Equity | -30.48% -106.06% | 503.05% +194.48% | -532.46% +585.26% | -77.70% -1,271.48% | |
Revenue Growth | 4.36% -67.81% | 13.54% +296.28% | -6.90% -171.13% | 9.69% -50.69% | |
Current Ratio | 0.96 +2.87% | 0.94 +48.10% | 0.63 -29.28% | 0.90 -20.42% | |
Cash Ratio | 0.24 -40.37% | 0.41 +237.61% | 0.12 -73.90% | 0.47 -9.64% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow